Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q4 2019?

130 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q4 2019. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q4 2019 13F Holders as of 31 Dec 2019

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 51,033,735
Total 13F value: $828,265,787
Share change: +8,103,203
Put/Call ratio: 135%
SEC-reported price per share: $16.23
Number of holders: 130
Value change: +$132,605,351
Number of buys: 80
Number of sells: 39
Shares outstanding: 104,661,494

Security key

761330109

Report period

Q4 2019

Institutions

130

Top holders

RVNC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Revance Therapeutics, Inc. SEC filings Revance Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 761330109

Newer quarter: Q3 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

WELLINGTON MANAGEMENT GRO...

Disclosed value leader

WELLINGTON MANAGEMENT GRO...

Comparable rows

0/15

Latest evidence

30 Sep 2019

13F Highest disclosed value: $70,349,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP has the largest disclosed position value at $70.35M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.

Disclosed position value Top 5

WELLINGTON MANAGEMENT GROUP LLP $70.35M

ArrowMark Colorado Holdings LLC $62.81M

FRANKLIN TEMPLETON INC $46.37M

BlackRock Finance, Inc. $46.36M

Essex Woodlands Management, Inc. $43.45M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	— denominator unverified	$70,349,000 5,411,472 shares	—	30 Sep 2019
ArrowMark Colorado Holdings LLC	13F Company 13F	— denominator unverified	$62,811,000 4,831,653 shares	—	30 Sep 2019
FRANKLIN TEMPLETON INC	13F Company 13F	— denominator unverified	$46,366,000 3,566,575 shares	—	30 Sep 2019
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$46,357,000 3,565,971 shares	—	30 Sep 2019
Essex Woodlands Management, Inc.	13F Company 13F	— denominator unverified	$43,447,000 3,342,047 shares	—	30 Sep 2019
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$34,512,000 2,654,772 shares	—	30 Sep 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

130

51,033,735

Rows available

130

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2019 holders

130

Holder diff

129

Investor	Q3 2025 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2025 value	Q4 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend